Geode Capital Management
ASPX

Geode Capital Management’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Geode Capital Management’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-106,924
Closed -$10.7M – 4039
2015
Q1 		$10.7M Buy
106,924
+32,612
+44% +$2.17M 0.01% 1334
2014
Q4 		$3.9M Buy
74,312
+1,301
+2% +$38.2K ﹤0.01% 1978
2014
Q3 		$1.87M Buy
73,011
+19,239
+36% +$409K ﹤0.01% 2395
2014
Q2 		$1.2M Buy
53,772
+11,476
+27% +$251K ﹤0.01% 2690
2014
Q1 		$1.3M Buy
+42,296
New +$1.14M ﹤0.01% 2612

Geode Capital Management's ASPX Position: Q2 2015 in Review

Geode Capital Management sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 106,924 shares — an estimated $10.7M sold.

Geode Capital Management first reported a position in ASPX in Q1 2014 and held it in 5 quarters. The position peaked at $10.7M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Geode Capital Management reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Geode Capital Management sold 106,924 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $10.7M.
  • Geode Capital Management first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 5 quarters.
  • Geode Capital Management's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $10.7M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Geode Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.